Literature DB >> 26056716

Vascularization strategies of engineered tissues and their application in cardiac regeneration.

Xuetao Sun1, Wafa Altalhi2, Sara S Nunes3.   

Abstract

The primary function of vascular networks is to transport blood and deliver oxygen and nutrients to tissues, which occurs at the interface of the microvasculature. Therefore, the formation of the vessels at the microcirculatory level, or angiogenesis, is critical for tissue regeneration and repair. Current strategies for vascularization of engineered tissues have incorporated multi-disciplinary approaches including engineered biomaterials, cells and angiogenic factors. Pre-vascularization of scaffolds composed of native matrix, synthetic polymers, or other biological materials can be achieved through the use of single cells in mono or co-culture, in combination or not with angiogenic factors or by the use of isolated vessels. The advance of these methods, together with a growing understanding of the biology behind vascularization, has facilitated the development of vascularization strategies for engineered tissues with therapeutic potential for tissue regeneration and repair. Here, we review the different cell-based strategies utilized to pre-vascularize engineered tissues and in making more complex vascularized cardiac tissues for regenerative medicine applications.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Cardiac regeneration; Cardiomyocytes; Endothelial cells; Stem cells; Tissue engineering; Vascularization; Vessels

Mesh:

Substances:

Year:  2015        PMID: 26056716     DOI: 10.1016/j.addr.2015.06.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  28 in total

Review 1.  Cellular Based Strategies for Microvascular Engineering.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Denis Pasic; Anoosha Forghani; Shane Lince; Daniel J Hayes; Ibrahim T Ozbolat; Dino J Ravnic
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

2.  Maturation of Human Stem Cell-derived Cardiomyocytes in Biowires Using Electrical Stimulation.

Authors:  Xuetao Sun; Sara S Nunes
Journal:  J Vis Exp       Date:  2017-05-06       Impact factor: 1.355

Review 3.  Engineered circulatory scaffolds for building cardiac tissue.

Authors:  Shixing Huang; Yang Yang; Qi Yang; Qiang Zhao; Xiaofeng Ye
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 4.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

5.  Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems.

Authors:  Yosuke K Kurokawa; Rose T Yin; Michael R Shang; Venktesh S Shirure; Monica L Moya; Steven C George
Journal:  Tissue Eng Part C Methods       Date:  2017-08       Impact factor: 3.056

Review 6.  Bioprinting Approaches to Engineering Vascularized 3D Cardiac Tissues.

Authors:  Nazan Puluca; Soah Lee; Stefanie Doppler; Andrea Münsterer; Martina Dreßen; Markus Krane; Sean M Wu
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 7.  3D bioprinting for cardiovascular regeneration and pharmacology.

Authors:  Haitao Cui; Shida Miao; Timothy Esworthy; Xuan Zhou; Se-Jun Lee; Chengyu Liu; Zu-Xi Yu; John P Fisher; Muhammad Mohiuddin; Lijie Grace Zhang
Journal:  Adv Drug Deliv Rev       Date:  2018-07-24       Impact factor: 15.470

8.  Multi-Material Tissue Engineering Scaffold with Hierarchical Pore Architecture.

Authors:  Kathy Ye Morgan; Demetra Sklaviadis; Zachary L Tochka; Kristin M Fischer; Keith Hearon; Thomas D Morgan; Robert Langer; Lisa E Freed
Journal:  Adv Funct Mater       Date:  2016-06-13       Impact factor: 18.808

Review 9.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

10.  Type I Diabetes Delays Perfusion and Engraftment of 3D Constructs by Impinging on Angiogenesis; Which can be Rescued by Hepatocyte Growth Factor Supplementation.

Authors:  Wafa Altalhi; Rupal Hatkar; James B Hoying; Yasaman Aghazadeh; Sara S Nunes
Journal:  Cell Mol Bioeng       Date:  2019-05-21       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.